KORY JAMES WENTWORTH - Chief Financial Officer at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

KORY JAMES WENTWORTH - trading volume in the past year for Entrada Therapeutics, Inc.

Holdings reported by KORY JAMES WENTWORTH for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 137,987 $1,691,016 $12.25 04 Mar 2026 Direct
Stock Option (Right to Buy) 66,600 01 Mar 2026 Direct Common Stock

Transactions reported by KORY JAMES WENTWORTH for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.